David Wiest

18PUBLICATIONS
109CO-AUTHORS
Cancer diagnosisMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Medical roboticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 19, 2026
ATF4 coordinates amino acid and nucleotide synthesis with selective protein translation to ensure proper DNA replication timing in leukemia cells.

|Aug 26, 2025
TIM-3 and γδ T cells: new players in breast cancer dissemination.

Lorenzo Galluzzi, Claudia Galassi, David L Wiest

|Nov 27, 2024
TCF1 dosage determines cell fate during T cell development.

Anjali Verma, Bridget Aylward, Fei Ma

|Jun 13, 2024
E proteins control the development of NKγδT cells through their invariant T cell receptor.

Ariana Mihai, Sang-Yun Lee, Susan Shinton

|Oct 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.

Ying Wang, Shan He, Gennaro Calendo

|Aug 24, 2023
Doubling down to make killer T cells.

Dietmar Kappes, David L Wiest

Pageof 3

Frequent Collaborators

3 joint publications

Shawn P Fahl

3 joint publications

Alejandra V Contreras

2 joint publications

Roland L Dunbrack

2 joint publications

Susan Shinton